Estimating activity of the drug Peglyated Asparginase in children with Blood cancer (Acute Lymphoblastic Leukemia)
Not Applicable
Completed
- Conditions
- Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]
- Registration Number
- CTRI/2021/08/036033
- Lead Sponsor
- Manipal Academy of Higher Education
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
All children less than 18 years with Acute Lymphoblastic Leukemia/Lymphoblastic Leukemia on
curative intent and receiving Pegylated L Asparginase
Exclusion Criteria
Any child with Acute Lymphoblastic Leukemia and Downs Syndrome
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method